Page 2 - Cassava Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alzheimer s Drug Trial Results Questioned After Damning FDA Inspection Report - Cassava Sciences (NASDAQ:SAVA)

The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following a critical inspection report by the Food and Drug Administration.

New yorkUnited statesHoau yan wangMatthew schragCassava sciencesCity university of new yorkCassava sciences incVanderbilt universityDrug administrationInformation actCity universitySciences incHoau yan wang andCassava scienceBenzinga neuroBenzinga ecosystem

Integrity Issues Rampant in AD Research, Say Investigators

Investigative sleuths say the rewards are high while consequences are almost nonexistent, all while investigations take years to complete.

United statesTemple universityUniversity of southern californiaColumbia universityNew yorkVanderbilt universityStanford universityRichard morrisDror kolodkin galDomenico praticoLos angelesDominco praticoMarc tessier lavigneBerislavv zlokovicElizabeth mcnallyHoau yan wang

Cassava Sciences Reports Full-year 2023 Financial Results

$121.1 Million In Cash and Cash Equivalents at December 31, 2023, With an Additional $21.8 Million Raised In 2024 From Exercise of Warrants.A Total of Over.

United statesPuerto ricoSouth koreaNew yorkPierre gravierRemi barbierEric schoenRobert anderson jrCassava sciences incCochin institute parisCity university of new yorkDrug administrationOrrick herrington sutcliffeCassava sciencesCompany board of directorsResearch international

Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates

Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSouth koreaPuerto ricoRobert anderson jrEric schoenPierre gravierRemi barbierCassava sciences incDrug administrationCity university of new yorkCochin institute parisResearch internationalCompany board of directorsCassava sciencesOrrick herrington sutcliffe

Cassava Sciences And Alzheimer s Disease: Opaque Clarity (NASDAQ:SAVA)

Cassava Sciences And Alzheimer s Disease: Opaque Clarity (NASDAQ:SAVA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofDrug administrationCassava sciencesColors hunterCassava scienceDisease assessment scale cognitiveMini mental state examination